BMJ Open Diabetes Research & Care最新文献

筛选
英文 中文
Longitudinal changes in diet quality and food intake before and after diabetes awareness in American adults: the Coronary Artery Risk Development in Young Adults (CARDIA) study 美国成年人认识糖尿病前后饮食质量和食物摄入量的纵向变化:年轻人冠状动脉风险发展(CARDIA)研究
IF 4.1 2区 医学
BMJ Open Diabetes Research & Care Pub Date : 2024-03-01 DOI: 10.1136/bmjdrc-2023-003800
EunSeok Cha, Yuni Choi, Michael Bancks, Melissa Spezia Faulkner, Sandra B Dunbar, Guillermo E Umpierrez, Jared Reis, Mercedes R Carnethon, James M Shikany, Fengxia Yan, David R Jacobs
{"title":"Longitudinal changes in diet quality and food intake before and after diabetes awareness in American adults: the Coronary Artery Risk Development in Young Adults (CARDIA) study","authors":"EunSeok Cha, Yuni Choi, Michael Bancks, Melissa Spezia Faulkner, Sandra B Dunbar, Guillermo E Umpierrez, Jared Reis, Mercedes R Carnethon, James M Shikany, Fengxia Yan, David R Jacobs","doi":"10.1136/bmjdrc-2023-003800","DOIUrl":"https://doi.org/10.1136/bmjdrc-2023-003800","url":null,"abstract":"Introduction Limited longitudinal research is available examining how American adults make dietary changes after learning they have diabetes. We examined the associations between diabetes awareness and changes in dietary quality and food intake in a prospective cohort from the Coronary Artery Risk Development in Young Adults (CARDIA) study. Research design and methods A nested case-control design was used. In the original CARDIA study, black and white participants were recruited from four US urban areas and partitioned into one control group (no diabetes over 30-year follow-up) and three case groups (early-onset, intermediate-onset, later-onset diabetes groups) based on timing of diagnosis and first awareness of diabetes. Estimated mean A Priori Diet Quality Score (APDQS), and food subgroup intake were examined at three CARDIA examinations (year (Y)0, Y7, and Y20). The mean APDQS with 95% CIs and food intake (servings/day) were compared across the one control group and three case groups using exam-specific and repeated measures linear regression. Results Among 4576 participants (mean age: 25±4 years; 55% female; 49% black race), 653 incident cases (14.3%) of diabetes were observed over 30 years. APDQS was lowest at Y0 when the diabetes-free participants were aged 18–30 years (61.5–62.8), but increased over 20 years with advancing age across all groups (64.6–73.3). Lower APDQS in young adulthood was associated with a higher incidence of diabetes later in life. Diabetes awareness was associated with a net increase of 2.95 points in APDQS. The greatest increase of APDQS was when people learned of their diabetes for the first time (an increase of 5.71 in early-onset and 6.64 in intermediate-onset diabetes groups, respectively). Conclusions Advancing age and diabetes awareness were associated with more favorable dietary changes leading to improved diet quality. Optimal diet quality and healthy food intake in young adulthood seem important to prevent diabetes later in life. Data are available on reasonable request after the approval of the CARDIA P&P committee.","PeriodicalId":9151,"journal":{"name":"BMJ Open Diabetes Research & Care","volume":"148 1","pages":""},"PeriodicalIF":4.1,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140056323","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Loneliness and the risk of type 2 diabetes 孤独与罹患 2 型糖尿病的风险
IF 4.1 2区 医学
BMJ Open Diabetes Research & Care Pub Date : 2024-03-01 DOI: 10.1136/bmjdrc-2023-003934
Siri Rosenkilde, Sofie Have Hoffmann, Anne Bonde Thorsted, Trine Allerslev Horsbøl, Katrine Rich Madsen, Sara Fokdal Lehn, Allan Kofoed-Enevoldsen, Peter Bindslev Iversen, Marie Stjerne Grønkjær, Lau Caspar Thygesen
{"title":"Loneliness and the risk of type 2 diabetes","authors":"Siri Rosenkilde, Sofie Have Hoffmann, Anne Bonde Thorsted, Trine Allerslev Horsbøl, Katrine Rich Madsen, Sara Fokdal Lehn, Allan Kofoed-Enevoldsen, Peter Bindslev Iversen, Marie Stjerne Grønkjær, Lau Caspar Thygesen","doi":"10.1136/bmjdrc-2023-003934","DOIUrl":"https://doi.org/10.1136/bmjdrc-2023-003934","url":null,"abstract":"Introduction The incidence of type 2 diabetes is increasing globally. Recent research suggests that loneliness could be a potential risk factor for the development of type 2 diabetes. We aimed to investigate the association between loneliness and type 2 diabetes and the modifying effect of mental disorders. Research design and methods We conducted a prospective study including 465 290 adults (aged ≥16 years) who participated in either the Danish Health and Morbidity Survey or the Danish National Health Survey between 2000 and 2017. Loneliness was based on self-report, while type 2 diabetes was measured using an algorithm combining several health registers including type 2 diabetes patients treated both within the hospital sector and general practice. Cox proportional hazards regressions were used to estimate hazard ratios (HRs) and 95% confidence intervals (95% CIs). Results During a mean follow-up time of 6.3 years, 13 771 individuals (3%) developed type 2 diabetes. Feeling lonely once in a while was associated with a 14% increased risk of type 2 diabetes (95% CI 1.09 to 1.20), while feeling lonely often was associated with a 24% increased risk (95% CI 1.14 to 1.34), independent of sociodemographic factors and body mass index. The association was stronger among individuals without a mental disorder (HR 1.21, 95% CI 1.10 to 1.34 among those feeling lonely often) compared with those with a mental disorder (HR 1.07, 95% CI 0.93 to 1.23). Conclusions Loneliness independently increased the risk of type 2 diabetes. The effect was more pronounced in individuals without a mental disorder, as having a mental disorder itself likely increases the risk of type 2 diabetes. These findings emphasize the importance of addressing loneliness as a modifiable risk factor in preventing type 2 diabetes. Data may be obtained from a third party and are not publicly available.","PeriodicalId":9151,"journal":{"name":"BMJ Open Diabetes Research & Care","volume":"10 1","pages":""},"PeriodicalIF":4.1,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140116985","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Variation in the relationship between fasting glucose and HbA1c: implications for the diagnosis of diabetes in different age and ethnic groups 空腹血糖与 HbA1c 之间关系的差异:对不同年龄和种族群体糖尿病诊断的影响
IF 4.1 2区 医学
BMJ Open Diabetes Research & Care Pub Date : 2024-03-01 DOI: 10.1136/bmjdrc-2023-003470
Yashesvini Ram, Yongjin Xu, Alan Cheng, Timothy Dunn, Ramzi A Ajjan
{"title":"Variation in the relationship between fasting glucose and HbA1c: implications for the diagnosis of diabetes in different age and ethnic groups","authors":"Yashesvini Ram, Yongjin Xu, Alan Cheng, Timothy Dunn, Ramzi A Ajjan","doi":"10.1136/bmjdrc-2023-003470","DOIUrl":"https://doi.org/10.1136/bmjdrc-2023-003470","url":null,"abstract":"Introduction Identify non-glycemic factors affecting the relationship between fasting plasma glucose (FPG) and glycated hemoglobin (HbA1c), in order to refine diabetes diagnostic criteria. Research design and methods Relationship between FPG–HbA1c was assessed in 12 531 individuals from 2001 to 2018 US National Health and Nutrition Examination Survey. Using a recently described method, FPG and HbA1c were used to calculate apparent glycation ratio (AGR) of red blood cells for different subgroups based on age, race, and gender. Results At an FPG of 7 mmol/L, black individuals had a higher HbA1c (p<0.001, mean: 50.2 mmol/mol, 95% CI (49.8 to 50.4)) compared with white individuals (47.4 mmol/mol (47.2 to 47.5)). This corresponds to NGSP (National Glycohemoglobin Standardization Program) units of 6.7% and 6.5% for black versus white individuals, respectively. Similarly, individuals under 21 years had lower HbA1c (p<0.001, 47.9 mmol/mol (47.7 to 48.1), 6.5%) compared with those over 50 years (48.3 mmol/mol (48.2 to 48.5), 6.6%). Differences were also observed between women (p<0.001, 49.2 mmol/mol (49.1 to 49.3), 6.7%) and men (47.0 mmol/mol (46.8 to 47.1), 6.5%). Of note, the difference in HbA1c at FPG of 7 mmol/L in black females over 50 and white males under 21 years was 5 mmol/mol (0.46%). AGR differences according to race (p<0.001), age (p<0.001), and gender (p<0.001) explained altered glucose–HbA1c relationship in the analyzed groups. Conclusions FPG–HbA1c relationship is affected by non-glycemic factors leading to incorrect diagnosis of diabetes in some individuals and ethnic groups. Assessment of AGR helps understand individual-specific relationship between glucose levels and HbA1c, which has the potential to more accurately diagnose and manage diabetes. Data are available in a public, open access repository. Data were compiled from the National Health and Nutrition Examination Survey (NHANES) cohorts, between the period of 2001 and 2018 which are publicly available on the US Centers for Disease and Control website.","PeriodicalId":9151,"journal":{"name":"BMJ Open Diabetes Research & Care","volume":"56 1","pages":""},"PeriodicalIF":4.1,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140033296","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Role of perirenal adiposity in renal dysfunction among CKD individuals with or without diabetes: a Japanese cross-sectional study 肾周脂肪在伴有或不伴有糖尿病的慢性肾功能衰竭患者肾功能障碍中的作用:一项日本横断面研究
IF 4.1 2区 医学
BMJ Open Diabetes Research & Care Pub Date : 2024-03-01 DOI: 10.1136/bmjdrc-2023-003832
Teruyuki Kono, Gulinu Maimaituxun, Hayato Tanabe, Moritake Higa, Haruka Saito, Kenichi Tanaka, Hiroaki Masuzaki, Masataka Sata, Junichiro J. Kazama, Michio Shimabukuro
{"title":"Role of perirenal adiposity in renal dysfunction among CKD individuals with or without diabetes: a Japanese cross-sectional study","authors":"Teruyuki Kono, Gulinu Maimaituxun, Hayato Tanabe, Moritake Higa, Haruka Saito, Kenichi Tanaka, Hiroaki Masuzaki, Masataka Sata, Junichiro J. Kazama, Michio Shimabukuro","doi":"10.1136/bmjdrc-2023-003832","DOIUrl":"https://doi.org/10.1136/bmjdrc-2023-003832","url":null,"abstract":"Introduction It remains unclear whether increased perirenal fat (PRF) accumulation is equally related to renal involvement in patients with and without diabetes mellitus (DM). We evaluated the association between PRF volume (PRFV) and low glomerular filtration rate (GFR) and proteinuria in people with or without type 2 diabetes mellitus (T2DM). Research design and methods We performed a cross-sectional analysis of 473 individuals without T2DM (non-DM, n=202) and with T2DM (DM, n=271). PRFV (cm3), obtained from non-contrast CT, was indexed as PRF index (PRFV/body surface area, cm3/m2). Multivariate-adjusted models were used to determine the ORs of PRFV and PRFV index for detecting estimated GFR (eGFR) decrease of <60 mL/min/1.73 m2 proteinuria onset, or both. Results Although body mass index (BMI), visceral fat area, and waist circumference were comparable between the non-DM and DM groups, kidney volume, PRFV, and PRFV index were higher in individuals with T2DM than in those without T2DM. In the multivariate analysis, after adjusting for age, sex, BMI, hypertension, smoking history, and visceral fat area ≥100 cm2, the cut-off values of PRFV index were associated with an eGFR<60 in individuals with DM (OR 6.01, 95% CI 2.20 to 16.4, p<0.001) but not in those without DM. Conclusions PRFV is associated with low eGFR in patients with T2DM but not in those without T2DM. This suggests that PRF accumulation is more closely related to the onset and progression of diabetic kidney disease (DKD) than non-DKD. Clarifying the mechanisms through which PRF influences DKD development could pave the way for novel prevention and treatment strategies. Data are available upon reasonable request. All datasets generated and/or analyzed during the current study are not publicly available but are available from the corresponding author on reasonable request.","PeriodicalId":9151,"journal":{"name":"BMJ Open Diabetes Research & Care","volume":"1 1","pages":""},"PeriodicalIF":4.1,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140106613","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Influence of diabetes and other risk factors on in-hospital mortality following kidney transplantation: an analysis of the Spanish National Hospital Discharge Database from 2016 to 2020 糖尿病和其他风险因素对肾移植术后院内死亡率的影响:2016 年至 2020 年西班牙国家医院出院数据库分析
IF 4.1 2区 医学
BMJ Open Diabetes Research & Care Pub Date : 2024-03-01 DOI: 10.1136/bmjdrc-2023-003799
Ana Lopez-de-Andres, Rodrigo Jimenez-Garcia, Marta Lopez-Herranz, José Javier Zamorano-Leon, David Carabantes-Alarcon, Valentin Hernandez-Barrera, Javier de Miguel-Diez, Francisco Carricondo, Barbara Romero-Gomez, Natividad Cuadrado-Corrales
{"title":"Influence of diabetes and other risk factors on in-hospital mortality following kidney transplantation: an analysis of the Spanish National Hospital Discharge Database from 2016 to 2020","authors":"Ana Lopez-de-Andres, Rodrigo Jimenez-Garcia, Marta Lopez-Herranz, José Javier Zamorano-Leon, David Carabantes-Alarcon, Valentin Hernandez-Barrera, Javier de Miguel-Diez, Francisco Carricondo, Barbara Romero-Gomez, Natividad Cuadrado-Corrales","doi":"10.1136/bmjdrc-2023-003799","DOIUrl":"https://doi.org/10.1136/bmjdrc-2023-003799","url":null,"abstract":"Introduction To assess time trends in incidence, clinical characteristics, complications, and hospital outcomes among patients with type 1 diabetes (T1D), with type 2 diabetes (T2D), and patients without diabetes who underwent kidney transplant (KT); to identify variables associated with in-hospital mortality (IHM); and to determine the impact of the COVID-19 pandemic. Research design and methods We used a nationwide discharge database to select KT recipients admitted to Spanish hospitals from 2016 to 2020. We stratified patients according to diabetes status. We used multivariable logistic regression to identify the variables associated with IHM. Results A total of 14 594 KTs were performed in Spain (T2D, 22.28%; T1D, 3.72%). The number of KTs rose between 2016 and 2019 and and decreased from 2019 to 2020 in all groups. In patients with T2D, the frequency of KT complications increased from 21.08% in 2016 to 34.17% in 2020 (p<0.001). Patients with T2D had significantly more comorbidity than patients with T1D and patients without diabetes (p<0.001). Patients with T1D experienced KT rejection significantly more frequently (8.09%) than patients with T2D (5.57%). COVID-19 was recorded in 26 out of the 2444 KTs performed in 2020, being found in 6 of the 39 patients deceased that year (15.38%) and in 0.83% of the survivors. The variables associated with IHM were comorbidity and complications of KT. The presence of T1D was associated with IHM (OR 2.6; 95% CI 1.36 to 5.16) when patients without diabetes were the reference category. However, T2D was not associated with a higher IHM (OR 0.86; 95% CI 0.61 to 1.2). Conclusions The COVID-19 pandemic led to a decrease in the number of transplants. Patients with T1D have more rejection of the transplanted organ than patients with T2D. Fewer women with T2D undergo KT. The presence of T1D is a risk factor for IHM. Data may be obtained from a third party and are not publicly available.","PeriodicalId":9151,"journal":{"name":"BMJ Open Diabetes Research & Care","volume":"56 1","pages":""},"PeriodicalIF":4.1,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140603215","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
External validation and application of the Diabetes Population Risk Tool (DPoRT) for prediction of type 2 diabetes onset in the US population 外部验证和应用糖尿病人口风险工具 (DPoRT) 预测美国人口中 2 型糖尿病的发病情况
IF 4.1 2区 医学
BMJ Open Diabetes Research & Care Pub Date : 2024-03-01 DOI: 10.1136/bmjdrc-2023-003905
Kathy Kornas, Christopher Tait, Ednah Negatu, Laura C Rosella
{"title":"External validation and application of the Diabetes Population Risk Tool (DPoRT) for prediction of type 2 diabetes onset in the US population","authors":"Kathy Kornas, Christopher Tait, Ednah Negatu, Laura C Rosella","doi":"10.1136/bmjdrc-2023-003905","DOIUrl":"https://doi.org/10.1136/bmjdrc-2023-003905","url":null,"abstract":"Introduction Characterizing diabetes risk in the population is important for population health assessment and diabetes prevention planning. We aimed to externally validate an existing 10-year population risk model for type 2 diabetes in the USA and model the population benefit of diabetes prevention approaches using population survey data. Research design and methods The Diabetes Population Risk Tool (DPoRT), originally derived and validated in Canada, was applied to an external validation cohort of 23 477 adults from the 2009 National Health Interview Survey (NHIS). We assessed predictive performance for discrimination (C-statistic) and calibration plots against observed incident diabetes cases identified from the NHIS 2009–2018 cycles. We applied DPoRT to the 2018 NHIS cohort (n=21 187) to generate 10-year risk prediction estimates and characterize the preventive benefit of three diabetes prevention scenarios: (1) community-wide strategy; (2) high-risk strategy and (3) combined approach. Results DPoRT demonstrated good discrimination (C-statistic=0.778 (males); 0.787 (females)) and good calibration across the range of risk. We predicted a baseline risk of 10.2% and 21 076 000 new cases of diabetes in the USA from 2018 to 2028. The community-wide strategy and high-risk strategy estimated diabetes risk reductions of 0.2% and 0.3%, respectively. The combined approach estimated a 0.4% risk reduction and 843 000 diabetes cases averted in 10 years. Conclusions DPoRT has transportability for predicting population-level diabetes risk in the USA using routinely collected survey data. We demonstrate the model’s applicability for population health assessment and diabetes prevention planning. Our modeling predicted that the combination of community-wide and targeted prevention approaches for those at highest risk are needed to reduce diabetes burden in the USA. Data are available in a public, open access repository. The NHIS data are available from www.cdc.gov/nchs/nhis/index.htm.","PeriodicalId":9151,"journal":{"name":"BMJ Open Diabetes Research & Care","volume":"214 1","pages":""},"PeriodicalIF":4.1,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140056443","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Postprandial glucose variability and clusters of sex hormones, liver enzymes, and cardiometabolic factors in a South African cohort of African ancestry 南非非裔队列中的餐后血糖变异性与性激素、肝酶和心脏代谢因素的群集
IF 4.1 2区 医学
BMJ Open Diabetes Research & Care Pub Date : 2024-03-01 DOI: 10.1136/bmjdrc-2023-003927
Bontle Masango, Julia H Goedecke, Michèle Ramsay, Karl-Heinz Storbeck, Lisa K Micklesfield, Tinashe Chikowore
{"title":"Postprandial glucose variability and clusters of sex hormones, liver enzymes, and cardiometabolic factors in a South African cohort of African ancestry","authors":"Bontle Masango, Julia H Goedecke, Michèle Ramsay, Karl-Heinz Storbeck, Lisa K Micklesfield, Tinashe Chikowore","doi":"10.1136/bmjdrc-2023-003927","DOIUrl":"https://doi.org/10.1136/bmjdrc-2023-003927","url":null,"abstract":"Introduction This study aimed to, first, determine the clusters of sex hormones, liver enzymes, and cardiometabolic factors associated with postprandial glucose (PPG) and, second to evaluate the variation these clusters account for jointly and independently with polygenic risk scores (PRSs) in South Africans of African ancestry men and women. Research design and methods PPG was calculated as the integrated area under the curve for glucose during the oral glucose tolerance test (OGTT) using the trapezoidal rule in 794 participants from the Middle-aged Soweto Cohort. Principal component analysis was used to cluster sex hormones, liver enzymes, and cardiometabolic factors, stratified by sex. Multivariable linear regression was used to assess the proportion of variance in PPG accounted for by principal components (PCs) and type 2 diabetes (T2D) PRS while adjusting for selected covariates in men and women. Results The T2D PRS did not contribute to the PPG variability in both men and women. In men, the PCs’ cluster of sex hormones, liver enzymes, and cardiometabolic explained 10.6% of the variance in PPG, with PC1 (peripheral fat), PC2 (liver enzymes and steroid hormones), and PC3 (lipids and peripheral fat) contributing significantly to PPG. In women, PC factors of sex hormones, cardiometabolic factors, and liver enzymes explained a similar amount of the variance in PPG (10.8%), with PC1 (central fat) and PC2 (lipids and liver enzymes) contributing significantly to PPG. Conclusions We demonstrated that inter-individual differences in PPG responses to an OGTT may be differentially explained by body fat distribution, serum lipids, liver enzymes, and steroid hormones in men and women. Data are available in a public, open access repository. Data are available upon reasonable request. The dataset used in this study is available in the European Genome-phenome Archive (EGA) database (<https://ega-archive.org/>) under the study accession code EGAS00001002482. The genotype dataset accession code is EGAD00010001996. The availability of these datasets is subject to controlled access through, the Data and Biospecimen Access Committee of the H3Africa Consortium. The augmented MASC data are available upon reasonable request.","PeriodicalId":9151,"journal":{"name":"BMJ Open Diabetes Research & Care","volume":"69 1","pages":""},"PeriodicalIF":4.1,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140056728","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Greater persistence and adherence to basal insulin therapy is associated with lower healthcare utilization and medical costs in patients with type 2 diabetes: a retrospective database analysis 基础胰岛素治疗的持续性和依从性越高,2 型糖尿病患者的医疗利用率和医疗费用就越低:一项回顾性数据库分析
IF 4.1 2区 医学
BMJ Open Diabetes Research & Care Pub Date : 2024-03-01 DOI: 10.1136/bmjdrc-2023-003825
Vanita R Aroda, Nick Nielsen, Kamal K Mangla, Jasjit Multani, Victoria Divino, Tarlan Namvar, Jigar Rajpura
{"title":"Greater persistence and adherence to basal insulin therapy is associated with lower healthcare utilization and medical costs in patients with type 2 diabetes: a retrospective database analysis","authors":"Vanita R Aroda, Nick Nielsen, Kamal K Mangla, Jasjit Multani, Victoria Divino, Tarlan Namvar, Jigar Rajpura","doi":"10.1136/bmjdrc-2023-003825","DOIUrl":"https://doi.org/10.1136/bmjdrc-2023-003825","url":null,"abstract":"Introduction We aimed to assess persistence and adherence to basal insulin therapy, their association with all-cause healthcare resource utilization (HCRU) and direct medical costs, and predictors of persistence and adherence in adults with type 2 diabetes. Research design and methods A retrospective cohort study was conducted with US adults with type 2 diabetes initiating basal insulin therapy between January 1, 2016, and December 31, 2018, using IQVIA PharMetrics Plus claims data. Persistence and adherence were assessed during 1 year post-initiation per previous definitions. Demographic/clinical characteristics were assessed during the 1 year pre-initiation. Inverse probability of treatment weighting (IPTW) was used to adjust for confounding variables. Post-IPTW, all-cause HCRU and direct medical costs were assessed during the first-year and second-year post-initiation by persistence and adherence status. Multivariable logistic regression was used to identify predictors of persistence and adherence. Results The final sample comprised 64,953 patients; 56.8% demonstrated persistence and 41.9% demonstrated adherence. Patients demonstrating persistence and adherence were significantly less likely to have a hospitalization than patients demonstrating non-persistence or non-adherence, respectively. In the second-year post-initiation, total mean all-cause direct medical costs per patient were lower for patients demonstrating persistence and significantly lower for patients demonstrating adherence. Prior use of both oral and injectable antidiabetic medication predicted persistence and adherence compared with patients with only prior oral antidiabetic medication use (persistence OR, 1.50 (95% CI, 1.44 to 1.57); adherence OR, 1.48 (95% CI, 1.42 to 1.55)). Conclusions Persistence and adherence to basal insulin was associated with fewer hospitalizations and lower direct medical costs. Data are available upon reasonable request. The underlying data sets used in this study are available with permission from IQVIA, but restrictions apply to the availability of these data, which were used under license for the current study and therefore are not publicly available.","PeriodicalId":9151,"journal":{"name":"BMJ Open Diabetes Research & Care","volume":"1 1","pages":""},"PeriodicalIF":4.1,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140033480","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Omentin associates with serum metabolite profiles indicating lower diabetes risk: KORA F4 Study 奥门冬酰胺与血清代谢物特征相关,表明糖尿病风险较低:KORA F4 研究
IF 4.1 2区 医学
BMJ Open Diabetes Research & Care Pub Date : 2024-03-01 DOI: 10.1136/bmjdrc-2023-003865
Jacqueline M Ratter-Rieck, Mengya Shi, Karsten Suhre, Cornelia Prehn, Jerzy Adamski, Wolfgang Rathmann, Barbara Thorand, Michael Roden, Annette Peters, Rui Wang-Sattler, Christian Herder
{"title":"Omentin associates with serum metabolite profiles indicating lower diabetes risk: KORA F4 Study","authors":"Jacqueline M Ratter-Rieck, Mengya Shi, Karsten Suhre, Cornelia Prehn, Jerzy Adamski, Wolfgang Rathmann, Barbara Thorand, Michael Roden, Annette Peters, Rui Wang-Sattler, Christian Herder","doi":"10.1136/bmjdrc-2023-003865","DOIUrl":"https://doi.org/10.1136/bmjdrc-2023-003865","url":null,"abstract":"Introduction Circulating omentin levels have been positively associated with insulin sensitivity. Although a role for adiponectin in this relationship has been suggested, underlying mechanisms remain elusive. In order to reveal the relationship between omentin and systemic metabolism, this study aimed to investigate associations of serum concentrations of omentin and metabolites. Research design and methods This study is based on 1124 participants aged 61–82 years from the population-based KORA (Cooperative Health Research in the Region of Augsburg) F4 Study, for whom both serum omentin levels and metabolite concentration profiles were available. Associations were assessed with five multivariable regression models, which were stepwise adjusted for multiple potential confounders, including age, sex, body mass index, waist-to-hip ratio, lifestyle markers (physical activity, smoking behavior and alcohol consumption), serum adiponectin levels, high-density lipoprotein cholesterol, use of lipid-lowering or anti-inflammatory medication, history of myocardial infarction and stroke, homeostasis model assessment 2 of insulin resistance, diabetes status, and use of oral glucose-lowering medication and insulin. Results Omentin levels significantly associated with multiple metabolites including amino acids, acylcarnitines, and lipids (eg, sphingomyelins and phosphatidylcholines (PCs)). Positive associations for several PCs, such as diacyl (PC aa C32:1) and alkyl-alkyl (PC ae C32:2), were significant in models 1–4, whereas those with hydroxytetradecenoylcarnitine (C14:1-OH) were significant in all five models. Omentin concentrations were negatively associated with several metabolite ratios, such as the valine-to-PC ae C32:2 and the serine-to-PC ae C32:2 ratios in most models. Conclusions Our results suggest that omentin may influence insulin sensitivity and diabetes risk by changing systemic lipid metabolism, but further mechanistic studies investigating effects of omentin on metabolism of insulin-sensitive tissues are needed. Data from this KORA Study are not publicly available because the data are subject to national data protection laws, and restrictions were imposed by the Ethics Committee of the Bavarian Chamber of Physicians to ensure data privacy of the study participants. However, data are available on request to researchers through a project agreement from KORA (<http://epi.helmholtz-muenchen.de/kora-gen/>). Requests should be sent to [kora.passt@helmholtz-muenchen.de][1] and are subject to approval by the KORA board. [1]: http://kora.passt@helmholtz-muenchen.de","PeriodicalId":9151,"journal":{"name":"BMJ Open Diabetes Research & Care","volume":"2 1","pages":""},"PeriodicalIF":4.1,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140033591","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Predictive biomarkers of rapidly developing insulin deficiency in children with type 1 diabetes. 1 型糖尿病儿童胰岛素缺乏症快速发展的预测性生物标志物。
IF 4.1 2区 医学
BMJ Open Diabetes Research & Care Pub Date : 2024-02-27 DOI: 10.1136/bmjdrc-2023-003924
Per Lundkvist, Annika Grönberg, Per-Ola Carlsson, Johnny Ludvigsson, Daniel Espes
{"title":"Predictive biomarkers of rapidly developing insulin deficiency in children with type 1 diabetes.","authors":"Per Lundkvist, Annika Grönberg, Per-Ola Carlsson, Johnny Ludvigsson, Daniel Espes","doi":"10.1136/bmjdrc-2023-003924","DOIUrl":"10.1136/bmjdrc-2023-003924","url":null,"abstract":"<p><strong>Introduction: </strong>The rate of progression to complete insulin deficiency varies greatly in type 1 diabetes. This constitutes a challenge, especially when randomizing patients in intervention trials aiming to preserve beta cell function. This study aimed to identify biomarkers predictive of either a rapid or slow disease progression in children with new-onset type 1 diabetes.</p><p><strong>Research design and methods: </strong>A retrospective, longitudinal cohort study of children (<18 years) with type 1 diabetes (N=46) was included at diagnosis and followed until complete insulinopenia (C-peptide <0.03 nmol/L). Children were grouped into rapid progressors (n=20, loss within 30 months) and slow progressors (n=26). A sex-matched control group of healthy children (N=45) of similar age was included for comparison. Multiple biomarkers were assessed by proximity extension assay (PEA) at baseline and follow-up.</p><p><strong>Results: </strong>At baseline, rapid progressors had lower C-peptide and higher autoantibody levels than slow. Three biomarkers were higher in the rapid group: carbonic anhydrase 9, corticosteroid 11-beta-dehydrogenase isozyme 1, and tumor necrosis factor receptor superfamily member 21. In a linear mixed model, 25 proteins changed over time, irrespective of group. One protein, a coxsackievirus B-adenovirus receptor (CAR) increased over time in rapid progressors. Eighty-one proteins differed between type 1 diabetes and healthy controls. Principal component analysis could not distinguish between rapid, slow, and healthy controls.</p><p><strong>Conclusions: </strong>Despite differences in individual proteins, the combination of multiple biomarkers analyzed by PEA could not distinguish the rate of progression in children with new-onset type 1 diabetes. Only one marker was altered significantly when considering both time and group effects, namely CAR, which increased significantly over time in the rapid group. Nevertheless, we did find some markers that may be useful in predicting the decline of the C-peptide. Moreover, these could potentially be important for understanding type 1 diabetes pathogenesis.</p>","PeriodicalId":9151,"journal":{"name":"BMJ Open Diabetes Research & Care","volume":"12 1","pages":""},"PeriodicalIF":4.1,"publicationDate":"2024-02-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10900379/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139982409","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信